Indonesia has received GFATM grants since 2003 with 17 grants worth $500 million across the three diseases. Grants have been awarded to the MOH, National AIDS Commission and civil society partners. Grants to the MOH are used to procure all ARVs and many of the ACTs and MDR-TB treatment regimens in Indonesia. Programs strengthen and expand DOTS, train health workers, strengthen communications and community outreach, build the capacity of national, regional and provincial laboratories, improve quality and reach of service delivery, including opportunistic infections, TB/HIV coinfection, PMTCT, counseling and testing, enhance the health information system; support indoor residual spraying control.
